$CYDY #OTCQB CytoDyn Inc. (CYDY: OTCQB) | CytoDyn’s Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab
Copyright 2021 – OTC Markets Group Inc.

News Link